PRA Health Sciences, Inc.
PRAHDelisted Jul 1, 2021- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001613859
PRA Health Sciences, Inc. was delisted on Jul 1, 2021; its insiders filed their last Form 4 on Jul 1, 2021; 317 institutions reported holding it in 13F filings for Q2 2021, worth $10.1B in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:42 PM ET
Revenue flow, FY2020
Where the revenue went in FY2020, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2021 | Feb 20, 2020 | Feb 27, 2019 | Feb 21, 2018 | Feb 22, 2017 |
| Revenue | $3.18B | $3.07B | $2.87B | $2.26B | $1.81B |
| Gross profit | – | – | – | $664.5M | – |
| Selling, general and administrative | $453.0M | $394.9M | $371.8M | $322.0M | $269.9M |
| Operating income | $328.1M | $363.9M | $281.3M | $176.2M | $162.3M |
| Income tax | $62.0M | $62.8M | $67.2M | -$12.6M | $28.5M |
| Net income | $197.0M | $243.0M | $153.9M | $86.9M | $68.2M |
| EPS, basic | $3.11 | $3.77 | $2.40 | $1.39 | $1.12 |
| EPS, diluted | $3.04 | $3.68 | $2.32 | $1.32 | $1.06 |
| Weighted shares, basic | 63.4M | 64.5M | 64.1M | 62.4M | 60.8M |
| Weighted shares, diluted | 64.8M | 66.0M | 66.3M | 65.8M | 64.5M |
| Margins and growth | |||||
| Gross margin | – | – | – | 29.4% | – |
| Operating margin | 10.3% | 11.9% | 9.8% | 7.8% | 9.0% |
| Net margin | 6.2% | 7.9% | 5.4% | 3.8% | 3.8% |
| Revenue growth, year over year | +3.8% | +6.8% | +27.1% | +24.7% | +12.3% |
| Net income growth, year over year | −18.9% | +57.9% | +77.1% | +27.5% | −16.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2021 | Feb 20, 2020 | Feb 27, 2019 | Feb 21, 2018 | Feb 22, 2017 |
| Cash and equivalents | $506.3M | $236.2M | $144.2M | $192.2M | $144.6M |
| Accounts receivable | $843.9M | $658.5M | $568.1M | $627.0M | $439.1M |
| Total current assets | $1.46B | $985.6M | $782.4M | $877.0M | $624.7M |
| Property, plant and equipment | $194.6M | $180.7M | $154.8M | $143.1M | $87.6M |
| Goodwill | $1.69B | $1.50B | $1.49B | $1.51B | $972.0M |
| Intangible assets | $599.9M | $638.6M | $704.4M | $783.8M | $474.0M |
| Total assets | $4.18B | $3.54B | $3.19B | $3.36B | $2.19B |
| Accounts payable | $56.9M | $55.3M | $43.7M | $64.6M | $51.3M |
| Short-term debt | $25.0M | $25.0M | $0 | $28.8M | $31.3M |
| Total current liabilities | $1.27B | $1.02B | $898.9M | $971.6M | $564.2M |
| Long-term debt | $1.16B | $1.14B | $1.08B | $1.23B | $797.1M |
| Total liabilities | $2.70B | $2.45B | $2.14B | $2.42B | $1.46B |
| Shareholders' equity | $1.48B | $1.09B | $1.05B | $936.5M | $729.3M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2021 | Feb 20, 2020 | Feb 27, 2019 | Feb 21, 2018 | Feb 22, 2017 |
| Operating cash flow | $427.2M | $253.6M | $329.8M | – | – |
| Capital expenditures | $66.8M | $74.3M | $55.9M | $61.3M | $33.1M |
| Free cash flow | $360.4M | $179.3M | $273.9M | – | – |
| Depreciation and amortization | $131.6M | $114.9M | $112.2M | $78.2M | $69.5M |
| Stock-based compensation | $69.4M | – | – | – | – |
| Share buybacks | $0 | $300.0M | – | – | – |
| Investing cash flow | -$233.9M | -$73.2M | -$55.5M | – | – |
| Financing cash flow | $77.4M | -$90.7M | -$319.5M | – | – |
| Net change in cash | $270.0M | $91.6M | -$48.2M | $43.6M | – |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.2% | – | – | – | – |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Apr 26, 2021 | 64.8M | +1.7% | SEC |
| Feb 19, 2021 | 64.5M | +1.5% | SEC |
| Oct 30, 2020 | 64.1M | +1.4% | SEC |
| Jul 31, 2020 | 64.0M | −2.9% | SEC |
| Apr 24, 2020 | 63.7M | −3.0% | SEC |
| Feb 14, 2020 | 63.6M | −3.0% | SEC |
| Oct 28, 2019 | 63.2M | −2.7% | SEC |
| Jul 29, 2019 | 65.9M | +2.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.